Arthritis Research & Therapy

official impact factor 4.36

Open Access Highly Access

Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase

Nancy J Ganson, Susan J Kelly, Edna Scarlett, John S Sundy and Michael S Hershfield*

Arthritis Research & Therapy 2006, 8:R12 doi:10.1186/ar1861

Accesses  

  • Last 30 days: 70 accesses
  • Last year: 990 accesses
  • All time: 8756 accesses

Cited by

BioMed Central: 1 citation

Review   Free Highly Accessed

Developments in the scientific and clinical understanding of gout

Alexander So Arthritis Research & Therapy 2008, 10:221 (10 October 2008)

This article is part of a collection on The Scientific Basis of...